Evaluation of an Innovative Speech-enabled Translator in Emergency Settings

Diagnoses Disease Clinical Trial

Official title:

Evaluation of an Innovative Speech-enabled Translator in Emergency Settings

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04788966
• Other study ID #: Réq 2017-00996
• Status: Completed
• Start date: November 29, 2018
• Est. completion date: January 20, 2020

Study information

• Verified date: March 2021
• Source: University Hospital, Geneva
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Survey-based satisfaction, performance and technical features evaluation of a speech-enabled fixed-phrase translation tool (BabelDR) in an emergency department.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 42
• Est. completion date: January 20, 2020
• Est. primary completion date: January 20, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• As per inclusion criteria, patients were required to have no understanding of French, thus making a diagnostic interview by the doctors impossible.

Exclusion Criteria:

• Exclusion criteria concerned patients who shared a common language with the doctor and/or were not able to read in their native language.

Related Conditions & MeSH terms

• Diagnoses Disease
• Emergencies

Intervention

Device:
• the translation tool BabelDr
Doctors use a speech-enabled fixed-phrase translation tool to help communicate with an allophone patient.

Locations

Country	Name	City	State
Switzerland	University Hospitals of Geneva (HUG)	Geneva

Sponsors (2)

Lead Sponsor	Collaborator
University Hospital, Geneva	University of Geneva, Switzerland

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Satisfaction evaluation through a 4-point scale survey	Are patients' and doctors' satisfied with the use of BabelDr?	During the consultation
Primary	Efficacy evaluation through a 2-point scale survey	Can BabelDr be efficient tool in an emergency context: are doctors' able to reach a diagnostic with the tool?	During the consultation
Primary	Technical features evaluation through a 4-point scale survey	Are the technical features appreciated by the doctors'?	During the consultation